| | Title | Author(s) | Year | View Count | | 1 |  | Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation | Fung, JYY; Cheung, C; Chan, SC; Yuen, MF; Chok, KSH; Sharr, W; Dai, WC; Chan, ACY; Cheung, TT; Tsang, S; Lam, B; Lai, CL; Lo, CM | 2011 | 585 |
| 2 | | Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection | Yuen, MF; Wong, DKH; Lee, CK; Tanaka, Y; Allain, JP; Fung, J; Leung, J; Lin, CK; Sugiyama, M; Sugauchi, F; Mizokami, M; Lai, CL | 2011 | 370 |
| 3 | | Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B | Fung, J; Lai, CL; Cheng, C; Wu, R; Wong, DKH; Yuen, MF | 2011 | 205 |
| 4 | | Three years of continuous entecavir therapy in treatment-nave chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety | Yuen, MF; Seto, WK; Fung, J; Wong, DKH; Yuen, JCH; Lai, CL | 2011 | 1,310 |
| 5 | | Treatment of chronic hepatitis B: Evolution over two decades | Yuen, MF; Lai, CL | 2011 | 407 |
| 6 |  | Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection | Chan, KYK; Wong, CM; Kwan, JSH; Lee, JMF; Cheung, KW; Yuen, MF; Lai, CL; Poon, RTP; Sham, PC; Ng, IOL | 2011 | 150 |
| 7 | | Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study | Fung, J; Lai, CL; Wong, DKH; Seto, WK; Hung, I; Yuen, MF | 2011 | 669 |
| 8 | | Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B | Fung, J; Lai, CL; Seto, WK; Wong, DKH; Yuen, MF | 2011 | 77 |
| 9 | | Nucleoside/nucleotide analogues in the treatment of chronic hepatitis b | Fung, J; Lai, CL; Seto, WK; Yuen, MF | 2011 | 47 |
| 10 | | Nucleic acid testing for the detection of HBV DNA | Seto, WK; Lai, CL; Yuen, MF | 2011 | 36 |
| 11 |  | Risk of liver cancer in patients with hepatitis B or C | Huang, JQ; Zheng, GF; Lai, CL; Yuen, RMF; Wong, BCY | 2011 | 53 |
| 12 | | Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment | Fung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF | 2011 | 249 |
| 13 | | Stability of hepatitis B surface antigen over time: Implications for studies using stored sera | Fung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF | 2011 | 150 |
| 14 | | Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy | Fung, J; Seto, WK; Lai, CL; Yuen, J; Wong, DKH; Yuen, MF | 2011 | 277 |
| 15 | | Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B | Yeung, P; Wong, DKH; Lai, CL; Fung, J; Seto, WK; Yuen, MF | 2011 | 126 |
| 16 | | Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years | Fung, J; Lai, CL; Yuen, J; Cheng, C; Wu, R; KaHo Wong, D; Seto, WK; Hung, IFN; Yuen, MF | 2011 | 541 |
| 17 | | Ketamine-induced cholangiopathy: A case report | Seto, WK; Ng, M; Chan, P; Ng, IOL; Cheung, SCW; Hung, IFN; Yuen, MF; Lai, CL | 2011 | 382 |
| 18 | | The effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6 | Seto, WK; Tanaka, Y; Liu, K; Lai, CL; Yuen, MF | 2011 | 345 |
| 19 | | A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B | Seto, WK; Lee, CF; Lai, CL; Ip, PPC; Fong, YT; Fung, J; Wong, KH; Yuen, MF | 2011 | 483 |
| 20 | | Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma | Wong, DKH; Huang, FY; Lai, CL; Poon, RTP; Seto, WK; Fung, J; Hung, IFN; Yuen, MF | 2011 | 309 |
|
